Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep;33(5):NP5-NP10.
doi: 10.1177/11206721221125852. Epub 2022 Sep 13.

Multimodal ocular imaging in Proteus syndrome

Affiliations
Case Reports

Multimodal ocular imaging in Proteus syndrome

Annabella Salerni et al. Eur J Ophthalmol. 2023 Sep.

Abstract

In this report we illustrate the ophthalmologic assessment of two patients affected by Proteus Syndrome (PS), an extremely rare genetic disorder. Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen. Case #2 describes a 20 year old female patient referred to our Ophthalmology Department for a routine ophthalmologic evaluation after being treated for 3 years with Miransertib (an experimental AKT-pathway inhibitor). Both patients underwent a complete ophthalmologic examination and a multimodal imaging evaluation. The multimodal imaging approach has revealed useful to evaluate both cases in detail and to keep track of disease evolution over time, moreover providing helpful features to further characterize this rare syndrome.

Keywords: Proteus syndrome; limbal dermoid cyst; miransertib; myopic chorioretinopathy; optic nerve drusen.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
(a) Limbal dermoid cyst in the inferotemporal quadrant in RE; (b) Peripheral superior cortical lens opacity with pigment on anterior surface of the lens in RE; (c) AS-OCT scan on the limbal dermoid cyst.
Figure 2.
Figure 2.
(a-b) RE tangential corneal tomography and pachymetry (with detected parameters); (c-d) LE tangential corneal tomography and pachymetry (with detected parameters); (e) RE anterior segment OCT with normal features, except for temporal margin where a limbal dermoid cyst is detected; (f) LE anterior segment OCT with normal features.
Figure 3.
Figure 3.
(a) RE fundus: severe myopic retinal-coroidosis and optic nerve drusen; (b) LE fundus: unremarkable retina, except for mild tilted optic nerve; (c-d) RE ultrasound B-Scan in 2013 and 2019: elevation of the optic nerve head (ONH) with medium reflectivity due to slightly calcified drusen; (e) Cranial CT-scan: ONH in RE slightly elevated and hyperintense compatible with mildly calcified drusen.
Figure 4.
Figure 4.
(a-b) RE tangential corneal tomography and pachymetry (with detected parameters); (c-d) LE tangential corneal tomography and pachymetry (with detected parameters); (e-f) RE and LE Anterior Segment OCT with normal features.
Figure 5.
Figure 5.
(a-b) RE and LE fundus with unremarkable retina; (c-f-g) ONH and RNFL OCT with normal feature in both eyes (except for RNFL symmetry); (d-e) RE and LE horizontal macular scan: physiological conformation of all macula layers.

References

    1. Biesecker LG, Sapp JC, et al. Proteus Syndrome. In: Adam MP, Ardinger HH, Pagon RA. (eds) GeneReviews®. Seattle: University of Washington, 1993–2021: 2–12. http://www.ncbi.nlm.nih.gov/books/NBK99495/ (accessed 8 November 2021). - PubMed
    1. Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365(7): 611–619. doi:10.1056/NEJMoa1104017. Epub 2011 Jul 27. - DOI - PMC - PubMed
    1. Biesecker LG, Happle R, Mulliken JB, et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 1999; 84(5): 389–395. doi:10.1002/(sici)1096-8628(19990611)84:5 - DOI - PubMed
    1. Cohen MM. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet 2014; 85(2): 111–119. doi:10.1111/cge.12266. Epub 2013 Oct 23. - DOI - PubMed
    1. Leoni C, Gullo G, Resta N, et al. First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma. Am J Med Genet A 2019; 179(7): 1319–1324. doi:10.1002/ajmg.a.61160. Epub 2019 May 6. - DOI - PubMed

Publication types

LinkOut - more resources